# Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD

> **NCT04882839** · PHASE2 · RECRUITING · sponsor: **Beersheva Mental Health Center** · enrollment: 15 (estimated)

## Conditions studied

- Obsessive-compulsive Disorder

## Interventions

- **COMBINATION_PRODUCT:** psychotherapy assisted psilocybin

## Key facts

- **NCT ID:** NCT04882839
- **Lead sponsor:** Beersheva Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-25
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04882839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04882839, "Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe OCD". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT04882839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*